UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000032153
Receipt number	R000036679
Scientific Title	A phase II neoadjuvant trial of sequential nab-paclitaxel followed by 5-fluorouracil/epirubicine/cyclophosphamide (FEC) in operable breast cancer
Date of disclosure of the study information	2018/04/09
Last modified on	2018/04/08 15:10:05

---